The purpose of this study is to examine the feasibility and preliminary efficacy of a psychosocial eHealth intervention designed to improve hormone therapy adherence among Hispanic/Latinx women with breast cancer. Our proposed secondary outcomes are health-related quality of life and self-efficacy in managing hormone therapy side effects. The intervention components include breast cancer knowledge, hormone/endocrine therapy knowledge, stress awareness and management, social support, and enhanced communication and intimacy skills. The intervention will be delivered via a Smartphone application over a 12-week period. All participants will receive the intervention application (described below). Aside from using the Smartphone application for the recommended 12 weeks, participation in this study includes three assessments: baseline (at the beginning of the research study), 6-week follow-up, and 12-week follow-up.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acceptability of My Guide: Usefulness
Timeframe: T3 (immediately following 12 week intervention)
Acceptability of My Guide: Satisfaction
Timeframe: T3 (immediately following 12 week intervention)
Acceptability of My Guide: Learnability
Timeframe: T3 (immediately following 12 week intervention)
Acceptability of My Guide: Usability
Timeframe: T3 (immediately following 12 week intervention)
Demand of My Guide: Recruitment Rate
Timeframe: 12 weeks
Demand of My Guide: Retention Rate
Timeframe: 12 weeks
Participant use of My Guide: Number of Login's
Timeframe: 12 weeks
Participant use of My Guide: Duration of Usage
Timeframe: 12 weeks
Participant use of My Guide: Content Accessed
Timeframe: 12 weeks
Change in Medication adherence will be assessed primarily with the Adherence to Refills and Medication Scale (ARMS).
Timeframe: T1 (prior to starting intervention), T2 (6 weeks into intervention), T3 (immediately following 12 week intervention)